Markers that predict omalizumab response identified

May 2, 2016

(HealthDay)—Baseline serum periostin levels and levels of serum free immunoglobulin E (IgE) during treatment follow-up may be useful in assessing response to omalizumab treatment for asthma, according to a study published online April 26 in Allergy.

Tomoko Tajiri, from Kyoto University in Japan, and colleagues assessed the utility of biomarkers of type 2 inflammation (free serum IgE levels) in predicting omalizumab responses. Response was defined as the absence of asthma exacerbation during the first year of treatment. The study included 30 patients who were treated with omalizumab for at least one year, with 27 of them treated for two years.

The researchers found that patients without exacerbations during the first year of treatment had significantly higher baseline serum periostin levels and blood eosinophil counts than patients with exacerbations. There was a negative association between baseline serum periostin levels, but not eosinophil counts, and free serum IgE levels after 16 or 32 weeks of treatment. Reduced exacerbation numbers at two years were seen in those with reduced free serum IgE levels during treatment. For the 14 who had exacerbations during the first year of treatment, exacerbation numbers gradually and significantly decreased over the two-year study period, with simultaneous significant reductions in free serum IgE levels.

"Baseline serum periostin levels and serum free IgE levels during treatment follow-up may be useful in evaluating responses to omalizumab treatment," conclude the authors.

Several authors report financial ties to the pharmaceutical industry. One author disclosed a patent application for serum periostin for treatment of bronchial asthma.

Explore further: Preventive topical steroids cut atopic dermatitis severity

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Preventive topical steroids cut atopic dermatitis severity

April 28, 2016
(HealthDay)—Intermittent preventive administration of topical corticosteroids in children controls the severity of atopic dermatitis (AD), according to a study published online April 14 in the Journal of Dermatology.

Omalizumab decreases colds in inner-city children with asthma, study reports

March 6, 2016
Treatment with omalizumab significantly decreases the number of colds in inner-city children with allergic asthma, researchers reported at a press conference today at the American Academy of Allergy, Asthma and Immunology ...

Elevated carcinoembryonic antigen described in anorexia

March 30, 2016
(HealthDay)—In a case report published online March 25 in the International Journal of Eating Disorders, elevated serum carcinoembryonic antigen (CEA) levels are observed in a male patient with anorexia nervosa (AN).

Vitamin D deficiency ups odds of asthma exacerbation

December 5, 2014
(HealthDay)—Vitamin D deficiency is associated with increased odds of asthma exacerbations, according to a study published in the December issue of Allergy.

Investigational treatment provides hope for some chronic liver disease sufferers

April 16, 2016
A new study presented today provides hope for a new treatment in patients with primary sclerosing cholangitis, a rare condition characterised by inflammation and scarring in the bile ducts of the liver and for which there ...

Serotonin levels low in ankylosing spondylitis

October 3, 2015
(HealthDay)—Patients with ankylosing spondylitis (AS) have lower serotonin levels than healthy controls and patients with rheumatoid arthritis (RA), according to a study published online Sept. 30 in the Journal of Bone ...

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.